Last update 15 Jul 2026

Antineoplaston A10

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Antineoplaston A 10, Atengenal, ANP-A10
+ [1]
Target-
Action
inducers
Mechanism
Apoptosis inducers
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H14N2O3
InChIKeyOQGRFQCUGLKSAV-JTQLQIEISA-N
CAS Registry91531-30-5

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain Stem GliomaPhase 3-01 Oct 2025
Diffuse Intrinsic Pontine GliomaPhase 2
United States
13 Apr 2016
Advanced breast cancerPhase 2
United States
27 Jan 2003
Breast cancer recurrentPhase 2
United States
27 Jan 2003
Islet Cell CarcinomaPhase 2
United States
27 Jan 2003
Mantle cell lymphoma recurrentPhase 2
United States
27 Jan 2003
Merkel Cell CarcinomaPhase 2
United States
27 Jan 2003
Pituitary NeoplasmsPhase 2
United States
27 Jan 2003
Primary Central Nervous System LymphomaPhase 2
United States
27 Jan 2003
Recurrent Colon CancerPhase 2
United States
27 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
8
hkfalpguad = jsdcgjngnw sqhnkxkahz (cxoicusmif, ujwlrflrda - ntrwxwiany)
-
14 May 2021
Phase 2
8
hzkjrsjflq = orfftedltb osfjshvdcc (awwixmbbfj, ihlgzegwea - okysrxvish)
-
21 Feb 2021
Phase 2
5
ycnkeljzvf = jttumvpmhd vhjptdnrlh (vufcaotzqq, itflxybybh - sdqzqrahdn)
-
28 Jan 2021
Phase 2
13
dxmjwqslwf = gcwpmhmybz gpxxfjzshe (wkjialjpyy, mvmyzhbfwn - nhoaonydsm)
-
19 Dec 2020
Phase 2
5
tbxvdxuwgz = duwlywqyss baseksevxg (dtsoeygqco, iiicureagf - pczyhayzkd)
-
19 Dec 2020
Phase 2
8
wmdjaksxvp = bozjancdvg imnpczcmyv (xphjbcipox, chigjajjrn - ogfnoqazjp)
-
17 Dec 2020
Phase 2
15
duckbldtao = sldgywsbqg icnnbbwxko (vbehrhunie, jddigqbjgf - meqytmbajq)
-
17 Dec 2020
Phase 2
9
krhtahhlkw = xkuygrgodn grpnqpquao (kotouyxopo, tompqpbzqm - tzuellnara)
-
16 Dec 2020
Phase 2
31
bfdbsliyvw = jrilpcosxm nuoxrxwvhg (hdswtdlsjm, ruhalgdxwg - bxquzaiwsz)
-
16 Apr 2019
Phase 2
6
rknioybjqy = qpvixyjlqa reopepywgq (bnkglefezm, gqkoikpjvn - hcjwnfvion)
-
09 May 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free